SARTORIUS BIA SEPARATIONS D.O.O.
Desconocido
Yscript: Yeast cell factory for mRNA bioproduction
SARTORIUS BIA SEPARATIONS SEPARACIJSKE TEHNOLOGIJE D.O.O.
participó en un
HORIZON EUROPE:
HORIZON-EIC-2021-PATHFINDEROPEN-01
Messenger RNA (mRNA) vaccines have become a game-changer in the fight against COVID-19, providing an exit strategy to the global crisis of o...
2022-03-15 - 2025-03-31 | Financiado
2022-03-15 - 2025-03-31 | Financiado
HTP-GLYCOMET: Methods for high throughput glycoproteomic analysis
SARTORIUS BIA SEPARATIONS SEPARACIJSKE TEHNOLOGIJE D.O.O.
participó en un
FP7:
The main aim of the HTP-GlycoMet proposal is to develop technologies, which will enable high-throughput analysis of glycosylation of individ...
Financiado
Financiado
HIGHGLYCAN: Methods for high throughput HTP analysis of protein glycosylation
SARTORIUS BIA SEPARATIONS SEPARACIJSKE TEHNOLOGIJE D.O.O.
participó en un
FP7:
Glycosylation is a post-translational modification that enriches protein complexity and function. Dysregulation of glycosylation is associat...
Financiado
Financiado
PROT-HISPRA: HIgh Speed PRoteomics Analysis Prot HiSPRA Solving the bottlenecks of proteomics technologies for...
SARTORIUS BIA SEPARATIONS SEPARACIJSKE TEHNOLOGIJE D.O.O.
participó en un
FP7:
The main objective of the proposed collaborative project Prot-HiSPRA is to remove time-consuming bottlenecks of existing proteomics technolo...
Financiado
Financiado
INTENSO: Gaining Productivity Cost Efficiency and Sustainability in the Downstreaming Processing of Bio Prod...
SARTORIUS BIA SEPARATIONS SEPARACIJSKE TEHNOLOGIJE D.O.O.
participó en un
FP7:
The European Life science and chemical industries increasingly depend on effi-cient, sustainable, and cost-effective bioprocessing platforms...
Financiado
Financiado
* No se disponen de datos de la empresa actual.